Psychedelic-Assisted Psychotherapy-The New Frontier Part 1

Psychedelic-Assisted Psychotherapy-The New Frontier: A Highly Effective Treatment for Depression, Anxiety, PTSD, Suicidality, and End-of-Life Existential Angst with Christina Ingenito, LCSW & Jim Matto-Shepard, PhD

Psychedelic-assisted psychotherapy consistently shows remarkable and dramatic results from the serious psychological distresses of treatment-resistant depression, anxiety, PTSD, and end-of-life existential angst. Clients and clinical trial participants describe these experiences as one of the most spiritual of their lives. Increased compassion and empathy have also been consistently reported. Many voices of vision recognize these treatments as the most significant advancements in psychiatry and psychology in decades.

Our speakers will provide an embodied experience of psychedelic-assisted psychotherapy by sharing Christina’s personal experience as a participant in an MDMA research study, thus grounding the presentation in the palpable reality of the potent, healing effects of this treatment. Discussion will include currently available psychedelic-assisted psychotherapy treatments; highlight the importance of “set and setting;” and share what’s coming soon through the FDA MDMA Expanded Access program. They will also talk about their work as founders of the first psychedelic-assisted psychotherapy clinic in Sonoma County - the Northern California Center for Integrative Psychotherapy in Petaluma.

Learning Objectives - After completion of the presentation the attendees will:
1. Have a basic understanding of the protocol and effectiveness of ketamine-assisted psychotherapy (KAP), and understand the differences between KAP, ketamine infusions, and the new esketamine medication by Johnson & Johnson.

2. Understand the protocol of FDA-approved clinical trials utilizing MDMA-assisted psychotherapy, and have a clear understanding of the consistent and dramatic results of these trials. Understand what will be available through the FDA MDMA Expanded Access program coming in late 2019.

3. Understand the importance of “set and setting” in the psychedelic-assisted psychotherapy model and the non-directive clinical approach to the work.

About our speakers

Christina Ingenito, LCSW is a transpersonal and somatic psychotherapist with a private practice in Petaluma. She has been an LCSW since 1986, has done hospice work for over 25 years; and she facilitates a restorative justice group for men serving life in prison at San Quentin. She works at the intersection of mystery, social justice, and empowerment.

Jim Matto-Shepard, PhD is a licensed psychologist with specializations in somatic, couples and group psychotherapy. He was licensed in 1997. He is also a certified conscious dance (Soul Motion) teacher. Jim is passionate about authenticity in relationship and has been immersed in ritual and meditation since 1978.

Both Christina and Jim are certified in ketamine-assisted psychotherapy and are recent graduates of the CIIS Certificate in Psychedelic Therapies and Research Program. Along with two colleagues, they have founded and opened the first psychedelic-assisted psychotherapy clinic in Sonoma County — the Northern California Center for Integrative Psychotherapy in Petaluma.

https://www.temenos.center/